Amphastar Pharmaceuticals公司(股票代码:AMPH)在上交所正常交易时段内大跌10.71%,引发市场广泛关注。公司此前公布的第三季度财报显示,由于业绩疲弱未达预期,或引发了投资者担忧情绪,推动股价大跌。
根据财报,该公司第三季度调整后每股收益为0.96美元,低于去年同期的1.15美元,也未达到分析师预期的0.99美元。营收同比增长5.9%至1.91亿美元,但也低于分析师预期的1.95亿美元。该公司第三季度净收入为4043万美元。
分析师对该公司未来盈利预期也有所下调。过去三个月内,平均盈利预期下降约2.8%。尽管如此,分析师目前仍给予该股"买入"的平均评级,认为未来业绩或将好转。不过本次财报疲软表现可能加剧市场对其成长前景的担忧,推动股价大跌。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.